Download App

Log in to access Online Inquiry
Company Overview More
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
CEO: Stewart, Richard A. B.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > ACHV Achieve Life > Detailed Quotes

ACHV Achieve Life

6.950+0.120+1.76%
Close 05/18 20:00 ET
High
7.000
Open
6.980
Turnover
162.23K
Low
6.770
Pre Close
6.830
Volume
23.46K
Market Cap
67.29M
P/E(TTM)
Loss
52wk High
10.090
Shares
9.68M
P/E(Static)
Loss
52wk Low
5.621
Float Cap
55.91M
Bid/Ask %
0.00%
Historical High
1856247.281
Shs Float
8.04M
Volume Ratio
0.53
Historical Low
4.500
Dividend TTM
--
Div Yield TTM
--
P/B
3.14
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.29%
Amplitude
3.37%
Avg Price
6.914
Lot Size
1
Float Cap
55.91M
Bid/Ask %
0.00%
Historical High
1856247.281
Shs Float
8.04M
Volume Ratio
0.53
Historical Low
4.500
Dividend TTM
--
P/B
3.14
Dividend LFY
--
Turnover Ratio
0.29%
Amplitude
3.37%
Avg Price
6.914
Lot Size
1
Price Forecast

No Data

News

Comment